Position
Creative Planning in Sarepta Therapeutics, Inc.
Back to the book · All holders of SRPT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $20.2K$21.52 → $21.76
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 95.2K | $2.05M | — | — | — | 0.0% |
| Q1 2026 | 84.2K | $1.83M | $21.76 | $20.2K | −$237.3K | 0.0% |